Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2014-09-30
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tolerance of Cereals for Atopic Children
NCT01029184
Gluten-related Disorders in Familial Mediterranean Fever Patients
NCT03563300
Association Between Asthma and Food Allergy
NCT02884583
Molecular Analysis of IgE Antibodies in Walnut Allergic Patients
NCT02295267
Assessment of Orality Disorders in Children With Food Allergies
NCT04378335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laboratory workers with symptoms in presence of drosophila
blood test (four dry tubes 7ml) and prick tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood test (four dry tubes 7ml) and prick tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical symptoms in presence of drosophila
* The subject must be affiliated to a social security scheme
* Provision of informed consent prior to any study specific procedures
Exclusion Criteria
* antihistamine cure in progress
* Inability to understand the nature and goals of the study and / or communication difficulties with the investigator
* No affiliation to a French social security recipient or not such a scheme
* Major protected by law (guardianship, curator or under judicial protection)
* deprivation of liberty by judicial or administrative decision
* Increased likelihood of non compliance to the protocol or abandonment under study
* pregnancy or breastfeeding
18 Years
68 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Arnaud de Villeneuve
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UF 9410
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.